BioCentury
ARTICLE | Financial News

KaloBios amends IPO

January 31, 2013 2:08 AM UTC

Antibody company KaloBios Pharmaceuticals Inc. (South San Francisco, Calif.) amended its IPO and now plans to sell 8.3 million shares at $8-$9. An $8.50 price would raise $70.1 million and value the company at $198.8 million. Earlier this month, KaloBios amended its IPO to sell 3.9 million shares at $12-$14. The company proposed to raise up to $60 million in an IPO in October 2012 after becoming a publicly reporting company via the Form 10 pathway in August. Leerink; William Blair; and Needham are underwriters. ...